Laura Prendergast

Stock Analyst at Raymond James

(0.39)
# 3,949
Out of 4,784 analysts
9
Total ratings
37.5%
Success rate
-38.97%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Laura Prendergast

Erasca
Mar 26, 2025
Initiates: Outperform
Price Target: $5
Current: $1.52
Upside: +228.95%
Third Harmonic Bio
Feb 11, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $3.51
Upside: -
Mural Oncology
Oct 4, 2024
Initiates: Strong Buy
Price Target: $18
Current: $1.18
Upside: +1,425.42%
Nkarta
Aug 14, 2024
Upgrades: Strong Buy
Price Target: $16
Current: $2.00
Upside: +700.00%
Black Diamond Therapeutics
Jul 31, 2024
Initiates: Outperform
Price Target: $20
Current: $1.61
Upside: +1,142.24%
Revolution Medicines
Apr 10, 2024
Upgrades: Strong Buy
Price Target: $36$48
Current: $37.35
Upside: +28.51%